Purchase of human induced pluripotent stem cell-derived (hipsc) cells
Ended Purchase Order Awarded
- Contract number
- 75F40125P00102
- Awardee
-
Fujifilm Biosciences Inc. UEI NCTEKHZJ9293
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $89,655
Award facts
- Contract value 100% obligated
- $89,655.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a purchase order to Fujifilm Biosciences Inc. for human-induced pluripotent stem cell-derived (hiPSC) cells on July 1, 2025, with a firm fixed price ceiling of $89,655 and an ultimate completion date of June 29, 2026. Performance occurs in Silver Spring, Maryland. No small business set-aside applies to this commercial item acquisition.
Quick answers
Who was awarded contract 75F40125P00102?
75F40125P00102 was awarded to Fujifilm Biosciences Inc. by Food and Drug Administration (Department of Health and Human Services) on July 1, 2025.
How much is contract 75F40125P00102 worth?
The government has obligated $89,655 on 75F40125P00102.
Was contract 75F40125P00102 competed?
The extent of competition for 75F40125P00102 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award